80 related articles for article (PubMed ID: 3937341)
41. Effect of norepinephrine and angiotensin II on intrarenal oxygen availability.
Baker R; Beran AV; Strauss J
Adv Exp Med Biol; 1986; 200():403-12. PubMed ID: 3799328
[TBL] [Abstract][Full Text] [Related]
42. Mechanisms of blood pressure regulation by magnesium in man.
Rude R; Manoogian C; Ehrlich L; DeRusso P; Ryzen E; Nadler J
Magnesium; 1989; 8(5-6):266-73. PubMed ID: 2515398
[TBL] [Abstract][Full Text] [Related]
43. Influence of prostaglandin synthetase inhibitors on the renal effects of histamine.
Selkurt EE; Neel MA
Agents Actions; 1984 Oct; 15(3-4):254-9. PubMed ID: 6441467
[TBL] [Abstract][Full Text] [Related]
44. Angiotensin II in human veins: development of rapid desensitization and effect of indomethacin.
Harada K; Ohmori M; Kitoh Y; Sugimoto K; Fujimura A
Clin Exp Pharmacol Physiol; 1999 Dec; 26(12):959-63. PubMed ID: 10626062
[TBL] [Abstract][Full Text] [Related]
45. Pharmacological zero for electromagnetic renal blood flow measurement.
Jonker GJ; de Zeeuw D; Huisman RM; van der Hem GK
Pflugers Arch; 1985 Feb; 403(2):220-1. PubMed ID: 3982972
[TBL] [Abstract][Full Text] [Related]
46. Effects of continuous administration of angiotensin II on ventricular performance.
Downing SE; Sonnenblick EH
J Appl Physiol (1985); 1963 May; 18(3):585-592. PubMed ID: 31095361
[TBL] [Abstract][Full Text] [Related]
47. Renovascular effects of angiotensin II. A symposium. Budapest, Hungary, July 16-19, 1989. Proceedings.
Kidney Int Suppl; 1990 Nov; 30():S1-126. PubMed ID: 1979640
[No Abstract] [Full Text] [Related]
48. Angiotensin receptor blockers in diabetic nephropathy.
Price DA; Hollenberg NK
Curr Diab Rep; 2001 Dec; 1(3):267-74. PubMed ID: 12643209
[TBL] [Abstract][Full Text] [Related]
49. Tachyphylaxis of juxtaglomerular epithelioid cells to angiotensin II. Differences between the electrical membrane response and renin secretion.
Bührle CP; Hackenthal E; Nobiling R; Skøtt O; Baumbach L; Taugner R
Pflugers Arch; 1987 Sep; 410(1-2):55-62. PubMed ID: 3317271
[TBL] [Abstract][Full Text] [Related]
50. Intrarenal vascular effects of angiotensin II and angiotensin III in the dog.
Britton SL; Fiksen-Olsen MJ; Houck PC; Romero JC
J Hypertens; 1983 Jun; 1(1):95-101. PubMed ID: 6681031
[TBL] [Abstract][Full Text] [Related]
51. Specific desensitization of the canine renal vasculature to angiotensin II despite cyclo-oxygenase inhibition.
Meggs LG; Katzberg RW; DeLeeuw P; Hollenberg NK
Yale J Biol Med; 1985; 58(5):453-8. PubMed ID: 3937341
[TBL] [Abstract][Full Text] [Related]
52. Renal vascular tachyphylaxis to angiotensin II: specificity of the response for angiotensin.
de Leeuw PW; Meggs LG; Hollenberg NK
Life Sci; 1982 Mar; 30(10):813-9. PubMed ID: 7070197
[TBL] [Abstract][Full Text] [Related]
53. Effect of cyclooxygenase and thromboxane synthase inhibition on the response to angiotensin II in the hypoperfused canine kidney.
Goto F; Jackson EK; Ohnishi A; Herzer W; Branch RA
J Pharmacol Exp Ther; 1987 Dec; 243(3):799-803. PubMed ID: 3121844
[TBL] [Abstract][Full Text] [Related]
54. The effect of altered sodium balance upon renal vascular reactivity to angiotensin II and norepinephrine in the dog. Mechanism of variation in angiotensin responses.
Oliver JA; Cannon PJ
J Clin Invest; 1978 Mar; 61(3):610-23. PubMed ID: 641142
[TBL] [Abstract][Full Text] [Related]
55. Effects of renal nerve stimulation, norepinephrine and angiotensin II on renal blood flow in relation to release of PG-like substances in anesthetized dogs.
Satoh S; Ohyama Y; Hayashi M
Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):304-16. PubMed ID: 7337502
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
